Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
A Phase I/II, Open-Label Study of ADXS-503 Alone and in Combination with
Pembrolizumab in Subjects with Metastatic Squamous or Non-Squamous
Non-Small Cell Lung Cancer
A Phase III, Randomized, Double-blind Study of Encorafenib and Binimetinib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab in Previously Untreated BRAF V600E/K Mutation-Positive Participants with Unresectable or Metastatic Melanoma. STARBOARD
A Phase II Randomized, Open Label Study to Evaluate the Efficacy and Safety of
Golcadomide in Combination with Rituximab in Participants with Newly Diagnosed Advanced Stage
Follicular Lymphoma GOLSEEK-2
A prospective, multicenter, open-label single arm study evaluating the safety and efficacy of selective internal radiation therapy SIRT using SIR-Spheres Y-90 resin microspheres on duration of response DoR and objective response rate ORR in unresectable hepatocellular carcinoma HCC patients
DOORwaY90 Study
A Phase 2 Study of Veliparib ABT-888 and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma HGG without H3 K27M or BRAFV600 Mutations
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study
of Transarterial Chemoembolization TACE in Combination with either
Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in
Patients with Locoregional Hepatocellular Carcinoma EMERALD-1